The role of antral resection in sleeve gastrectomy. An observational comparative study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210628001

Enrollment

100

Registered

2021-06-28

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity, Diabetes Mellitus Type 2 Obesity

Interventions

Patients underwent to Sleeve Gastrectomy in which gastric resection starting 6 cm from the pylorus (LSG without antrectomy)

Treatment

6-DP group

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: BMI > 35 and diabetes mellitus type 2

Exclusion criteria

Exclusion criteria: Documented psychiatric disorders, alcohol or substance abuse, major diseases such as cancer or autoimmune diseases, corticosteroid therapy, DM2 duration <10 years and HbA1c >6.5%

Design outcomes

Primary

Measure	Time frame
weight loss 24 months %EWL ,Effect of extensive antrectomy on glucose metabolism 24 HbA1c level ,Effect of extensive antrectomy on basal plasma GLP-1 levels 24 Basal GLP-1 levels measured using a radioimmunoassay kit	—

Secondary

Measure	Time frame
Effect of extensive antrectomy on preoperative mobility an mortality 30 days after procedure Cliven Dindo scale	—

Countries

Italy

Contacts

Public ContactClementi Marco

University of L'Aquila

marco.clementi@univaq.it3355386225

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026